PUMA BIOTECHNOLOGY 06/01/2016 EGM
1Repeal any provisions of the By-laws of the Company in effect at the time of this proposal that was not included in the Bylaws as filed by the Company with the SEC on September 14, 2007.Oppose
2Remove, without cause, any person or persons, other than those elected pursuant to the Eshelman Consent SolicitationOppose
3Increase the size of the Board from five to nine directorsOppose
4.1Elect Fredric N. EshelmanOppose
4.2Elect James M. DalyOppose
4.3Elect Seth A. Rudnick Oppose
4.4Elect Kenneth B. Lee, JrOppose